NeuroSigma CEO and leadership

Leon Ekchian is NeuroSigma’s President and CEO. Prior to co-founding NeuroSigma in 2008, Leon served as President of Arrowhead Research Corporation, a publicly-traded company that commercializes innovative nanotechnologies in the electronic and biotech industries. Prior to Arrowhead, Leon served as President and CEO of Litex, a venture capital backed company which was spun out of Lockheed Martin, focused on commercializing an advanced automotive emission-control technology. Earlier, Leon worked as a business development executive at Lockheed Martin focusing on formation of new ventures, evaluating new business plans and licensing opportunities, and as a program manager at Litton Industries developing ground-based and airborne tracking systems.

Leon received a BS, MS and PhD in electrical engineering from MIT and an MBA from UCLA’s Anderson School of Management.

Chuck Winckler is a Chief Financial Officer at NeuroSigma Inc.

Carl Adams is a Vice President, Business Risk Assurance at TELEDYNE TECHNOLOGIES INC and VP/CFO/Controller at NeuroSigma Inc and is based in Los Angeles, California. He has worked as Co-founder, Executive Director at TAC-Solutions; Senior Manager at EY; and Practice Leader at Central New Mexico Community College. Carl attended California State University, Northridge between 1991 and 1993.

Global Biopharma and Med device marketing and sales executive with 35 years of extensive experience building high growth new specialty franchises creating value for patients, providers, payers and investors. Track record developing and launching new innovative products worldwide in multiple disease segments including biologics (BOTOX®) for Neurologic, Cosmetic, and Urologic conditions, pharmaceuticals for Ophthalmic and Dermatologic conditions and cataract medical devices. Possesses exceptional strategic marketing and management skills with a proven track record building and leading high performance teams

Specialties:

- Development of Specialty Franchise Plans including Orphan Diseases

- New Business / New Market Product Assessments

- Alliance / Partnership Management

- Product & Patent License Negotiations

- New Product Brand Development & Launches

- Customer Targeting Assessment and Field Deployment Modeling

- Market Access and Pricing

- Brand Economic Value & QOL Product Profile Development

- International Market Development (Canada, Europe, Asia, LATAM)

- R&D Portfolio Planning & Prioritizing

- Clinical Trial Design Consistent with Target Product Profile

- KOL & Clinical Investigator Advisory Development

- Specialty Sales and Sales Management

CEO/Co-Founder, HeartCloud.io. Director/Founder/CEO, Los Angeles TMS Institute. UCLA Professor Emeritus. CMO+SVP NeuroSigma. [he/him]

Leon Ekchian is NeuroSigma’s President and CEO. Prior to co-founding NeuroSigma in 2008, Leon served as President of Arrowhead Research Corporation, a publicly-traded company that commercializes innovative nanotechnologies in the electronic and biotech industries. Prior to Arrowhead, Leon served as President and CEO of Litex, a venture capital backed company which was spun out of Lockheed Martin, focused on commercializing an advanced automotive emission-control technology. Earlier, Leon worked as a business development executive at Lockheed Martin focusing on formation of new ventures, evaluating new business plans and licensing opportunities, and as a program manager at Litton Industries developing ground-based and airborne tracking systems.

Leon received a BS, MS and PhD in electrical engineering from MIT and an MBA from UCLA’s Anderson School of Management.